Free Pharmacology Hours- Reducing Cardioembolic Risk in A Fib

Optimal Strategies to Reduce Cardioembolic Risk in the Patient with Nonvalvular Atrial Fibrillation: A Patient Centered Approach- Identify the factor(s) in the coagulation cascade on which warfarin, dabigatran, rivaroxaban and apixaban exert their respective anticoagulant effects. Identify sources for evidence-based guidelines for antithrombotic therapy in the reduction of cardioembolic risk in the patient with non-valvular atrial fibrillation. Define the impact of renal function, clinical history, and patient age on the choice of anticoagulant agent. Describe the role of effective clinician/patient communication in the safe management of oral anticoagulation. Outline an efficient method of incorporating shared decision making when developing a treatment plan for the patient with NVAF.

2.25 Free CEUs for Nurse Practitioners which includes 1.0 Free Pharmacology Hours

This activity is supported in part by Bristol-Myers Squibb and Pfizer, Inc